Trial Profile
A single centre study of lenalidomide in patients with extranodal Diffuse Large B-cell Lymphoma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 01 Sep 2015
Price :
$35
*
At a glance
- Drugs Lenalidomide (Primary)
- Indications Diffuse large B cell lymphoma
- Focus Adverse reactions; Therapeutic Use
- 01 Sep 2015 New trial record